1433B_MACFA
ID 1433B_MACFA Reviewed; 246 AA.
AC Q4R572;
DT 22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT 23-JAN-2007, sequence version 3.
DT 03-AUG-2022, entry version 110.
DE RecName: Full=14-3-3 protein beta/alpha;
DE Contains:
DE RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;
GN Name=YWHAB; ORFNames=QccE-16215;
OS Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;
OC Cercopithecidae; Cercopithecinae; Macaca.
OX NCBI_TaxID=9541;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Brain cortex;
RG International consortium for macaque cDNA sequencing and analysis;
RT "DNA sequences of macaque genes expressed in brain or testis and its
RT evolutionary implications.";
RL Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC spectrum of both general and specialized signaling pathways. Binds to a
CC large number of partners, usually by recognition of a phosphoserine or
CC phosphothreonine motif. Binding generally results in the modulation of
CC the activity of the binding partner. Negative regulator of
CC osteogenesis. Blocks the nuclear translocation of the phosphorylated
CC form (by AKT1) of SRPK2 and antagonizes its stimulatory effect on
CC cyclin D1 expression resulting in blockage of neuronal apoptosis
CC elicited by SRPK2. Negative regulator of signaling cascades that
CC mediate activation of MAP kinases via AKAP13.
CC {ECO:0000250|UniProtKB:P31946}.
CC -!- SUBUNIT: Homodimer (By similarity). Interacts with SAMSN1 and PRKCE (By
CC similarity). Interacts with AKAP13. Interacts with SSH1 and
CC TORC2/CRTC2. Interacts with ABL1; the interaction results in
CC cytoplasmic location of ABL1 and inhibition of cABL-mediated apoptosis.
CC Interacts with ROR2 (dimer); the interaction results in phosphorylation
CC of YWHAB on tyrosine residues. Interacts with GAB2. Interacts with YAP1
CC (phosphorylated form). Interacts with the phosphorylated (by AKT1) form
CC of SRPK2. Interacts with PKA-phosphorylated AANAT. Interacts with
CC MYO1C. Interacts with SIRT2 (By similarity). Interacts with the 'Thr-
CC 369' phosphorylated form of DAPK2 (By similarity). Interacts with
CC PI4KB, TBC1D22A and TBC1D22B. Interacts with the 'Ser-1134' and 'Ser-
CC 1161' phosphorylated form of SOS1 (By similarity). Interacts (via
CC phosphorylated form) with YWHAB; this interaction occurs in a protein
CC kinase AKT1-dependent manner (By similarity). Interacts with SLITRK1.
CC Interacts with SYNPO2 (phosphorylated form); YWHAB competes with ACTN2
CC for interaction with SYNPO2 (By similarity). Interacts with RIPOR2 (via
CC phosphorylated form); this interaction occurs in a chemokine-dependent
CC manner and does not compete for binding of RIPOR2 with RHOA nor blocks
CC inhibition of RIPOR2-mediated RHOA activity (By similarity). Interacts
CC with MARK2 and MARK3 (By similarity). Interacts with TESK1; the
CC interaction is dependent on the phosphorylation of TESK1 'Ser-437' and
CC inhibits TESK1 kinase activity (By similarity). Interacts with MEFV (By
CC similarity). {ECO:0000250|UniProtKB:P31946,
CC ECO:0000250|UniProtKB:Q9CQV8}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P31946}.
CC Melanosome {ECO:0000250|UniProtKB:P31946}.
CC -!- ALTERNATIVE PRODUCTS:
CC Event=Alternative initiation; Named isoforms=2;
CC Name=Long;
CC IsoId=Q4R572-1; Sequence=Displayed;
CC Name=Short;
CC IsoId=Q4R572-2; Sequence=VSP_018633;
CC -!- PTM: The alpha, brain-specific form differs from the beta form in being
CC phosphorylated. Phosphorylated on Ser-60 by protein kinase C delta type
CC catalytic subunit in a sphingosine-dependent fashion. {ECO:0000250}.
CC -!- PTM: Isoform Short contains a N-acetylmethionine at position 1.
CC {ECO:0000250}.
CC -!- MISCELLANEOUS: [Isoform Short]: Inferred by similarity. {ECO:0000305}.
CC -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AB169672; BAE01753.1; -; mRNA.
DR RefSeq; XP_005569168.1; XM_005569111.2. [Q4R572-1]
DR RefSeq; XP_005569169.1; XM_005569112.1. [Q4R572-1]
DR RefSeq; XP_005569170.1; XM_005569113.1. [Q4R572-1]
DR AlphaFoldDB; Q4R572; -.
DR SMR; Q4R572; -.
DR IntAct; Q4R572; 1.
DR MINT; Q4R572; -.
DR STRING; 9541.XP_005569168.1; -.
DR Ensembl; ENSMFAT00000073733; ENSMFAP00000053407; ENSMFAG00000043236. [Q4R572-1]
DR GeneID; 101926442; -.
DR KEGG; mcf:101926442; -.
DR CTD; 7529; -.
DR VEuPathDB; HostDB:ENSMFAG00000043236; -.
DR eggNOG; KOG0841; Eukaryota.
DR GeneTree; ENSGT01050000244817; -.
DR OMA; KGCQLAR; -.
DR Proteomes; UP000233100; Chromosome 10.
DR Bgee; ENSMFAG00000043236; Expressed in temporal lobe and 13 other tissues.
DR GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR GO; GO:0042802; F:identical protein binding; IEA:UniProt.
DR GO; GO:0004860; F:protein kinase inhibitor activity; ISS:UniProtKB.
DR GO; GO:0045744; P:negative regulation of G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR Gene3D; 1.20.190.20; -; 1.
DR InterPro; IPR000308; 14-3-3.
DR InterPro; IPR023409; 14-3-3_CS.
DR InterPro; IPR036815; 14-3-3_dom_sf.
DR InterPro; IPR023410; 14-3-3_domain.
DR PANTHER; PTHR18860; PTHR18860; 1.
DR Pfam; PF00244; 14-3-3; 1.
DR PIRSF; PIRSF000868; 14-3-3; 1.
DR PRINTS; PR00305; 1433ZETA.
DR SMART; SM00101; 14_3_3; 1.
DR SUPFAM; SSF48445; SSF48445; 1.
DR PROSITE; PS00796; 1433_1; 1.
DR PROSITE; PS00797; 1433_2; 1.
PE 2: Evidence at transcript level;
KW Acetylation; Alternative initiation; Cytoplasm; Isopeptide bond; Nitration;
KW Phosphoprotein; Reference proteome; Ubl conjugation.
FT CHAIN 1..246
FT /note="14-3-3 protein beta/alpha"
FT /id="PRO_0000042983"
FT INIT_MET 1
FT /note="Removed; alternate"
FT /evidence="ECO:0000250|UniProtKB:P31946"
FT CHAIN 2..246
FT /note="14-3-3 protein beta/alpha, N-terminally processed"
FT /id="PRO_0000367901"
FT SITE 58
FT /note="Interaction with phosphoserine on interacting
FT protein"
FT /evidence="ECO:0000250"
FT SITE 129
FT /note="Interaction with phosphoserine on interacting
FT protein"
FT /evidence="ECO:0000250"
FT MOD_RES 1
FT /note="N-acetylmethionine"
FT /evidence="ECO:0000250|UniProtKB:P31946"
FT MOD_RES 2
FT /note="N-acetylthreonine; in 14-3-3 protein beta/alpha, N-
FT terminally processed"
FT /evidence="ECO:0000250|UniProtKB:P31946"
FT MOD_RES 2
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250|UniProtKB:P31946"
FT MOD_RES 5
FT /note="N6-acetyllysine"
FT /evidence="ECO:0000250|UniProtKB:P27348"
FT MOD_RES 51
FT /note="N6-acetyllysine; alternate"
FT /evidence="ECO:0000250|UniProtKB:P27348"
FT MOD_RES 60
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:Q9CQV8"
FT MOD_RES 70
FT /note="N6-acetyllysine"
FT /evidence="ECO:0000250|UniProtKB:P31946"
FT MOD_RES 84
FT /note="3'-nitrotyrosine"
FT /evidence="ECO:0000250|UniProtKB:Q9CQV8"
FT MOD_RES 106
FT /note="3'-nitrotyrosine"
FT /evidence="ECO:0000250|UniProtKB:Q9CQV8"
FT MOD_RES 117
FT /note="N6-acetyllysine"
FT /evidence="ECO:0000250|UniProtKB:P31946"
FT MOD_RES 186
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P68251"
FT MOD_RES 232
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P31946"
FT CROSSLNK 51
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2); alternate"
FT /evidence="ECO:0000250|UniProtKB:P27348"
FT VAR_SEQ 1..2
FT /note="Missing (in isoform Short)"
FT /evidence="ECO:0000305"
FT /id="VSP_018633"
FT MOD_RES Q4R572-2:1
FT /note="N-acetylmethionine"
FT /evidence="ECO:0000305"
SQ SEQUENCE 246 AA; 28082 MW; 6BE1A9BF97468017 CRC64;
MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL ELLDKYLIPN ATQPESKVFY
LKMKGDYFRY LSEVASGDNK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
AGEGEN
